CBD has not been shown to reliably treat insomnia. A few small studies have tested purified CBD on its own, but they have not found a consistent improvement in insomnia severity, time to fall asleep, time awake during the night, or overall sleep quality.
This answer can sound at odds with product reviews and personal reports. Some people do feel sleepy after taking CBD. Others use products that also contain THC, CBN, terpenes, or melatonin. Those experiences do not establish that CBD itself treats insomnia. They also cannot tell you whether the bottle contains what its label claims.
First, identify what the product actually contains
CBD, or cannabidiol, is one of many compounds found in cannabis. It does not usually produce the intoxication associated with THC, but the word CBD on a package does not describe a single standardized product.
Retail products are commonly marketed in several ways:
- CBD isolate is intended to contain CBD without other cannabinoids.
- Broad-spectrum CBD is marketed as containing CBD and other plant compounds, with THC removed.
- Full-spectrum CBD may contain CBD, THC, and other cannabinoids or plant compounds.
- Combination products may deliberately add THC, CBN, melatonin, herbs, or other ingredients.
These labels are not proof of the contents. Laboratory studies have repeatedly found differences between the CBD amount printed on a package and the amount measured in the product. Some nominally CBD products have also contained detectable THC 1 2.
There is also an important distinction between retail CBD and prescription cannabidiol. Epidiolex is a standardized, purified oral solution approved by the U.S. Food and Drug Administration for certain seizure disorders. It is not approved for insomnia. Its quality controls, prescribed doses, monitoring, and patient population differ from an over-the-counter oil or gummy 3 4.
What the research says about CBD and insomnia
The most useful evidence separates CBD-only treatment from products that contain other cannabinoids. When those categories are mixed together, positive findings from THC-containing or multi-ingredient products can be mistaken for evidence about CBD.
A 2025 systematic review pooled six randomized trials with 1,077 participants. Cannabinoid products as a broad group produced a statistically significant improvement in self-reported sleep quality, but the results varied greatly between studies. In the prespecified subgroup analysis, CBD-only treatments did not significantly improve sleep quality. The apparent benefit was concentrated in non-CBD cannabinoid formulations 5.
Current clinical guidance is similarly cautious. The 2025 VA/DoD guideline suggests against cannabis or its derivatives for chronic insomnia. This was a weak recommendation because the evidence was rated very low, not because large, definitive trials proved that every cannabinoid product is ineffective 6.
The main CBD-only insomnia trial was small
In a randomized pilot trial, 30 adults with moderate to severe primary insomnia took either 150 mg of sublingual CBD or placebo each night for two weeks. CBD did not outperform placebo on insomnia severity, self-reported time to fall asleep, self-reported sleep efficiency, or time awake after initially falling asleep. Most other sleep measures also showed no treatment difference 7.
The CBD group did have higher actigraphy-measured sleep efficiency after two weeks and reported better well-being during the trial. Those signals are worth further study, but they do not overturn the primary result. There were only 15 participants in each group, treatment lasted two weeks, and some baseline differences could have affected the comparisons. The 150 mg amount is a description of this experiment, not a recommended dose.
A healthy-volunteer study does not show an insomnia benefit
Another randomized crossover study gave 300 mg of CBD or placebo to 27 healthy adults before an overnight sleep study. CBD did not significantly change the measured sleep-wake cycle, sleep architecture, next-morning cognitive tests, or subjective measures 8.
That result does not prove CBD has no effect in people with insomnia. The participants were healthy, and each treatment was tested for only one night. It does show why claims that CBD increases deep sleep, extends REM sleep, or stabilizes sleep stages go beyond the available human evidence.
Mixed products cannot answer a CBD-only question
Studies of CBD combined with terpenes, THC, CBN, or melatonin test the complete formulation. Even when such a product improves a sleep measure, the study cannot show that CBD caused the change. The same problem applies to full-spectrum products whose cannabinoid content differs from a purified CBD study.
For this reason, evidence about a THC-containing cannabis product belongs in a broader discussion of cannabis and sleep. It should not be used to recommend CBD isolate, and findings from purified CBD should not be assumed to apply to every retail extract.
Feeling drowsy is not the same as treating insomnia
A substance can make someone feel sedated without improving the disorder that is disrupting sleep. Effective insomnia treatment should improve meaningful outcomes such as sleep continuity, distress about sleep, and daytime functioning, while keeping harms acceptably low.
Somnolence and sedation are known adverse effects of prescription cannabidiol. Its FDA label also lists insomnia, sleep disorder, and poor-quality sleep among adverse reactions reported in some seizure trials 4. These data come from people using prescription CBD for epilepsy, often at much higher weight-based doses and with other medicines. They do not predict exactly how a retail product will affect a particular person.
The key point is narrower: drowsiness is a side effect, not evidence that the underlying insomnia has improved. It may also be unsafe if it carries into driving, operating machinery, caregiving, or safety-sensitive work.
There is no established CBD dose, timing, or best form for sleep
Research has not established an effective CBD dose for insomnia. It also has not shown that gummies, capsules, oils, or full-spectrum products work better than one another.
The amounts used in experiments vary widely. The insomnia pilot tested 150 mg nightly for two weeks, while the healthy-volunteer study tested a single 300 mg dose 7 8. Neither result provides a dose to copy. Different formulations can also be absorbed differently, and a retail label may not accurately state the amount consumed.
Advice to take CBD a fixed number of minutes before bed or increase it until it works is therefore not evidence-based insomnia guidance. A higher amount may increase exposure and risk without producing a sleep benefit.
CBD safety deserves more attention than the label usually gives it
CBD is often described as natural and non-intoxicating. Neither word means risk-free. The most detailed safety information comes from prescription cannabidiol, while the contents and doses of retail products are less controlled.
Liver injury
The FDA-approved cannabidiol label warns about dose-related liver enzyme elevations and recommends liver testing in the prescription seizure setting. The risk was greater with some antiseizure medicines, particularly valproate, but elevations also occurred without those medicines 4.
A 2025 randomized trial extended this concern beyond patients with epilepsy. Healthy adults took CBD at 5 mg per kilogram of body weight per day or placebo for four weeks. Eight of 151 people assigned CBD developed liver enzyme levels more than three times the upper limit of normal, compared with none of the 50 people assigned placebo. The affected participants did not have symptoms, and their tests improved after CBD was stopped 9.
That weight-based study amount should not be treated as a typical retail dose or a threshold below which liver injury is impossible. It shows that clinically important liver changes can occur in healthy adults and may be silent.
Contact a clinician promptly if CBD use is followed by yellowing of the skin or eyes, dark urine, persistent nausea or vomiting, unusual fatigue, loss of appetite, or pain in the upper right abdomen. These symptoms can have many causes and should not be self-diagnosed.
Drug interactions and added sedation
CBD can change how the body processes some medicines. The prescription label includes clinically important interaction information for antiseizure medicines such as clobazam and valproate. It also warns that alcohol and other central nervous system depressants may increase sedation 4.
Retail CBD has not been tested with every prescription drug, over-the-counter medicine, or supplement. Ask a pharmacist or prescribing clinician to check the exact product and ingredient list before use if you take regular medication. This is especially important when a medicine already causes drowsiness, affects the liver, or needs carefully controlled blood levels.
Do not stop or change a prescribed medicine in order to try CBD.
Next-day alertness
A follow-up analysis of the 30-person insomnia pilot found no significant difference between CBD and placebo on the daytime cognitive tests used after two weeks. Dry mouth was reported more often with CBD 10.
This is reassuring within that small experiment, but it does not prove that CBD never impairs driving or work performance. The study involved a selected group of adults, one purified formulation, and a short treatment period. It did not test every dose, retail product, combination, or real-world driving situation.
Do not drive, operate machinery, or do safety-sensitive work if a product makes you sleepy, slowed, dizzy, or less attentive. The risk is different if the product also contains THC, alcohol, melatonin, or another sedating ingredient.
Pregnancy, breastfeeding, and younger people
The FDA strongly advises against using CBD, THC, or cannabis during pregnancy or while breastfeeding. Potential concerns include CBD transfer to a baby, effects on development that are not yet understood, interactions, and exposure to contaminants or undeclared THC 11.
Retail CBD is not an established sleep treatment for children or adolescents. The fact that prescription cannabidiol is approved for specific seizure disorders in patients age one and older does not make retail CBD appropriate for sleep problems in young people 3.
Keep gummies, oils, and capsules locked away from children and pets. Products that resemble candy can be taken accidentally.
Older adults
The main CBD-only insomnia trial enrolled adults aged 18 to 45, so it does not establish benefits or safety for older adults 7. Medication interactions, balance problems, and next-day sedation deserve particular attention when someone already takes several medicines or has a history of falls. A medication review is more useful than choosing a product based on the word natural.
Retail product quality can change the risk
A 2017 study tested 84 CBD products purchased online. Only 30 percent contained a CBD concentration within 10 percent of the label claim. THC was detected in 18 products, including some that did not make its presence clear 1.
A larger 2022 analysis tested labeling accuracy in 516 edible and topical CBD products. Forty-two percent were within 10 percent of the labeled CBD amount. The researchers also found detectable heavy metals and phthalates in portions of the edible products they tested 2.
These studies do not show that every retail product is mislabeled or contaminated. They do show that a package claim is not enough to verify the contents.
If an adult chooses to buy a CBD product despite the uncertain sleep benefit, a current certificate of analysis for the exact batch can provide limited information. Check whether it:
- matches the lot number and product name on the package
- reports the measured amount of CBD and THC per serving, not only a pass or fail statement
- includes testing for relevant contaminants, such as heavy metals, pesticides, residual solvents, and microbes
- names the independent laboratory and provides a recent test date
- accounts for added ingredients such as melatonin, CBN, herbs, or flavoring agents
A certificate does not prove that the product treats insomnia, is legal everywhere, is free of all contaminants, or cannot cause a positive drug test. It only reports what that laboratory measured in the submitted sample.
CBD and workplace drug testing
Standard workplace cannabis tests generally look for THC metabolites, not CBD. The practical problem is that full-spectrum products may contain THC, and a product marketed as THC-free may not match its label.
The U.S. Department of Transportation warns that CBD use can lead to a positive drug test. For workers covered by DOT drug-testing rules, claiming CBD use is not accepted as a medical explanation for a confirmed marijuana-positive result 12.
No product type can guarantee a negative test. If employment, military service, athletics, probation, or another program involves testing, check the applicable policy before using any cannabinoid product.
CBD legality is not a simple yes or no
Rules can differ by product composition, federal law, state or local law, and the way a product is marketed. A hemp-derived label does not by itself establish that a product is legal to sell or possess.
Federal law is also in transition. Congress changed the federal definition of hemp in November 2025, with the amended definition scheduled to take effect in November 2026. The change considers total THC and sets new limits that can affect some products previously marketed as hemp 13.
FDA rules are separate from the federal controlled-substance definition. The agency states that unapproved CBD products cannot legally be marketed as treatments for insomnia and that it is unlawful under current federal food and drug law to sell CBD as a dietary supplement or add it to food in interstate commerce 3.
Check current federal, state, local, employer, and travel rules rather than relying on a retailer's general legal claim.
If you already use CBD for sleep
You do not need to decide whether CBD works based on one unusually good or bad night. Sleep naturally varies, and expectations can affect how a night feels. A brief record can make the pattern easier to discuss with a clinician.
Write down:
- the exact product, lot number, and full ingredient list
- the labeled and laboratory-reported CBD and THC amount per serving
- when you took it and whether you used alcohol, cannabis, melatonin, or another sleep aid
- bedtime, estimated time to fall asleep, awakenings, final wake time, and next-day alertness
- new symptoms, medication changes, or other factors that could explain a change in sleep
Bring the product or a clear photograph of the label to a pharmacist or clinician. Do not keep increasing the amount to chase an effect that has not been established, and do not use a favorable response as a reason to ignore persistent insomnia or symptoms of another sleep disorder.
When sleep problems need proper evaluation
Seek an evaluation if trouble falling asleep or staying asleep keeps returning, affects daytime functioning, or continues for weeks. Loud snoring, witnessed breathing pauses, gasping, an uncontrollable urge to move the legs, marked mood changes, or severe daytime sleepiness can point to a problem that a CBD product will not diagnose.
Cognitive behavioral therapy for insomnia, or CBT-I, is the best-supported first-line treatment for chronic insomnia. It is a structured treatment that changes the behaviors and thought patterns that keep insomnia going. The 2025 VA/DoD guideline recommends CBT-I for chronic insomnia and suggests it over medication as first-line care 6.
This does not mean every short period of poor sleep requires therapy. It means persistent insomnia deserves an evidence-based plan rather than an indefinite series of unproven supplements.
Frequently asked questions
Does CBD make you high?
Purified CBD does not usually produce the intoxication associated with THC. A retail CBD product may still contain THC, either intentionally or because the contents do not match the label. Full-spectrum products are especially important to distinguish from CBD isolate.
Is full-spectrum CBD better for sleep than CBD isolate?
There is no good evidence that full-spectrum CBD is a better insomnia treatment. Full-spectrum products contain other compounds, so their effects and risks cannot be attributed to CBD alone. They may also expose a user to THC.
Can you take CBD every night?
Short trials do not establish the long-term benefits or safety of nightly retail CBD for insomnia. The main CBD-only insomnia trial lasted two weeks. Product variability, interactions, liver effects, and changes in other ingredients make broad claims about indefinite nightly use inappropriate 7 9.
What CBD dose helps with sleep?
No CBD dose has been established as effective for insomnia. Trial amounts are study details, not dosing instructions. Choosing an amount should not be based on marketing claims, a friend's response, or the assumption that more will work better.
Are gummies better than CBD oil for sleep?
No controlled evidence shows that gummies are a better insomnia treatment than oils or capsules. The form can change absorption and convenience, while added ingredients can change both effects and risks. The main question is not which form sounds most relaxing, but whether the exact product is supported, accurately labeled, and safe with your medications.
Can CBD cause a positive drug test?
Yes. CBD itself is not usually the target of workplace cannabis testing, but THC in a full-spectrum or mislabeled product can lead to a positive result. A THC-free claim or certificate of analysis cannot guarantee the outcome 12.
The bottom line
CBD is not a proven insomnia treatment. The strongest current synthesis found no significant improvement in sleep quality from CBD-only therapies, and the main dedicated insomnia trial found no benefit on insomnia severity or most sleep outcomes.
The uncertain benefit sits beside real practical risks: interactions, possible liver injury, sedation, inaccurate labels, undeclared THC, contaminants, drug-testing consequences, and changing legal rules. If sleep problems persist, focus on identifying the cause and using a treatment with stronger evidence, especially CBT-I for chronic insomnia.
